Food-as-Medicine Prescription Services Market Size, Share, Growth and Forecast (2026 - 2036)

What is the food-as-medicine prescription services market forecast to be worth by 2036?

USD 2.2 billion in 2026 to USD 35.0 billion by 2036, at 31.9% CAGR.

• The food-as-medicine prescription services market crossed a valuation of USD 1.7 billion in 2025.
• Demand is expected to increase from USD 2.2 billion in 2026 to USD 35.0 billion by 2036.
• The market is forecast to record 31.9% CAGR during 2026 to 2036 as Medicaid pilots and GLP-1 nutrition support expand.

What are the defining numbers behind food-as-medicine prescription services growth?

USD 32.8 billion absolute opportunity by 2036, led by the United States and Canada.

• Demand Drivers in the Market
  • Payers need nutrition interventions that can reduce avoidable chronic disease costs.
  • Clinicians need practical food prescriptions for diabetes and cardiovascular care.
  • Employers need nutrition support as GLP-1 use increases and metabolic care shifts.
  • Health plans need benefit platforms that can deliver food and track member engagement.
• Key Segments Analyzed
  • By Service Type: Medically Tailored Meals are expected to hold 36.0% share in 2026 because severe chronic disease patients need ready-to-eat therapeutic meals.
  • By Condition Focus: Diabetes leads because food choices directly affect glucose control. The share is projected at 34.0% in 2026.
  • By Customer Type: Health Plans and Payers are likely to account for 42.0% share in 2026 because reimbursement drives program scale.
  • By Delivery Model: Health-Plan Funded Benefit Programs lead as insurers fund eligible meals and produce. The model is projected to hold 40.0% share in 2026.
  • By End Use: Chronic Disease Cost Reduction is expected to hold 38.0% share in 2026 because payers need measurable medical savings.
  • By Geography: The United States is projected to record 35.2% CAGR through 2036 as Medicaid and employer-funded programs scale.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha, Senior Analyst at Fact.MR, states, “Food-as-medicine is becoming a reimbursed care service with a clear role in chronic disease management. Payers are looking at which food benefits can improve outcomes and reduce avoidable costs. Providers that combine clinical nutrition and delivery support will gain stronger access to chronic care budgets.”
• Strategic Implications
  • Health plans should link food benefits with disease management and member engagement programs.
  • Clinicians need referral workflows that make prescribed meals and groceries easy to access.
  • Food providers should build dietitian oversight and condition-specific nutrition standards.
  • Employers can use food-as-medicine support alongside GLP-1 and metabolic health programs.

Medically tailored meals and grocery-benefit services prescribed by clinicians and reimbursed by insurers to treat diet-related disease. HHS states that Food Is Medicine approaches integrate access to diet- and nutrition-related resources and that federal investment is supporting these approaches across settings. [1] This gives the market a policy base.

CMS states that Medicare Advantage plans can provide Special Supplemental Benefits for the Chronically Ill when the benefit has a reasonable expectation of improving or maintaining health or function. [2] This creates a payer route for food and nutrition services tied to chronic disease.

The United States is projected to record 35.2% CAGR from 2026 to 2036 as Medicaid and employer-funded programs scale. Canada is likely to post 33.6% CAGR as health plans and chronic care providers test nutrition support. The United Kingdom is expected to register 32.4% CAGR as food prescription models and social prescribing frameworks expand. Australia is forecast to advance at 31.5% CAGR as chronic disease and dietitian-led programs gain traction. Germany is set to record 30.2% CAGR by 2036 as payer interest in prevention and metabolic health rises.

How does the food-as-medicine prescription services market break down by segment?

Medically Tailored Meals lead at 36.0%; Diabetes leads at 34.0%.

Which service type dominates?

Medically Tailored Meals hold 36.0% share in 2026.

Medically Tailored Meals are expected to hold 36.0% share in 2026 because severe chronic disease patients need ready-to-eat therapeutic meals. HHS states that these meals are typically provided to patients with complex medical conditions and tailored by registered dietitian nutritionists. [3] Demand is strongest for people who cannot shop or manage complex diets without support. Meal providers also gain because prepared food creates the most direct clinical service model.

Which condition focus dominates?

Diabetes leads because food choices directly affect glucose control.

Diabetes leads because prescribed food programs can target blood sugar and cardiometabolic risk at the same time. The American Diabetes Association’s 2025 Standards of Care states that nutrition therapy plays an integral role in diabetes management and that people with diabetes should work with the care team to develop individualized eating plans [4]. The condition focus is projected to capture 34.0% share in 2026 as health plans test nutrition support for high-cost members. Diabetes programs can combine dietitian guidance with benefit-funded groceries or meals.

Which customer type dominates?

Health Plans and Payers hold 42.0% share in 2026.

Health Plans and Payers are likely to account for 42.0% share in 2026 because reimbursement drives program scale. CMS rules require Medicare Advantage plans to support SSBCI benefits with evidence that the items or services improve or maintain health or function. [2] Payers need food programs that can be documented and measured. This customer group leads because most eligible patients cannot pay for ongoing medically tailored food on their own.

Which delivery model dominates?

Health-Plan Funded Benefit Programs lead because reimbursed access creates scale.

Health-Plan Funded Benefit Programs lead because insurers can route members to meals, produce or grocery benefits through care management. The model is projected to hold 40.0% share in 2026 as Medicare Advantage and commercial plans test nutrition support.

Which end use dominates?

Chronic Disease Cost Reduction holds 38.0% share in 2026.

Chronic Disease Cost Reduction leads because payers need proof that food benefits reduce avoidable medical spend. The end use is expected to hold 38.0% share in 2026 as food-as-medicine programs target members with diabetes and renal disease.

What is accelerating food-as-medicine prescription services demand, and what is holding it back?

Payer pilots and GLP-1 nutrition needs drive demand; reimbursement complexity restrains adoption.

Payer coverage is the main driver of demand for food-as-medicine prescription services. HHS states that Medicaid managed care organizations may offer additional services that include Food Is Medicine interventions, while Medicare Advantage supplemental benefits can include meals and food or produce for chronically ill enrollees [5]. Health plans are looking at medically tailored meals and grocery benefits as tools to support members with chronic conditions. Coverage support can turn nutrition programs from optional wellness services into reimbursed care pathways.

The main restraint is reimbursement complexity. Food-as-medicine services are funded through different benefit pathways and health-plan contracts. Eligibility rules can vary by condition and plan type. Providers must manage clinical documentation and outcomes reporting before programs can scale across payers.

Where do the biggest food-as-medicine prescription service opportunities sit?

Medically tailored meals and GLP-1 nutrition support.

• Medically Tailored Meals: Providers can serve high-need chronic disease patients with ready-to-eat therapeutic meals.
• Produce Prescriptions: Platforms can fund fruits and vegetables for patients with cardiometabolic risk.
• GLP-1 Nutrition Support: Employers and plans can add protein and meal guidance during weight-management treatment.

Which countries are scaling food-as-medicine prescription services fastest?

United States 35.2%, Canada 33.6%, United Kingdom 32.4%, Australia 31.5%, Germany 30.2%.

Based on regional analysis, the food-as-medicine prescription services market is segmented into North America, Western Europe, Asia Pacific, Latin America, and Middle East and Africa.

What is powering the United States lead?

The United States is projected to record a 35.2% CAGR through 2036, supported by Medicaid and employer-funded program expansion. Demand will grow around diabetes care and post-discharge nutrition support. Providers that connect clinical referrals with measurable food delivery will gain stronger market access.

How is Canada scaling food-as-medicine prescription demand?

Canada is likely to post 33.6% CAGR through 2036 as health plans and chronic care providers test nutrition support. Diabetes and obesity create demand for structured food benefits. Canadian employers and insurers can use food-as-medicine services as part of chronic disease management. Providers will need culturally relevant food options and dietitian oversight. Demand will favor partnerships between insurers and community health providers.

What supports the United Kingdom outlook?

The United Kingdom is expected to register 32.4% CAGR through 2036 as food prescription models and social prescribing frameworks expand. NHS-linked social prescribing gives the country a pathway for food and nutrition referrals. Patients with diabetes and obesity need practical nutrition support beyond advice. Food-as-medicine services can connect dietitians and community organizations. Demand will favor produce prescriptions and medically tailored grocery models before prepared meal coverage reaches scale.

How is Australia scaling food-as-medicine prescription services?

Australia is forecast to advance at 31.5% CAGR through 2036 as chronic disease and dietitian-led programs gain traction. Food-as-medicine services can support people with diabetes and obesity through meal planning and healthy grocery access. Private insurers and employers may fund nutrition support to reduce long-term medical cost. Digital delivery makes programs easier to deploy across urban and regional populations. Demand will favor models that include registered dietitian support and measurable member engagement.

Why is Germany an important food-as-medicine market?

Germany is set to record 30.2% CAGR through 2036 as payer interest in prevention and metabolic health rises. German sickness funds and employers are likely to evaluate nutrition services as chronic disease costs increase. Food-as-medicine programs will need strong clinical governance, privacy safeguards and dietitian-led methods. Diabetes and cardiovascular disease care will be early focus areas. Demand will favor medically tailored groceries and counseling before large prepared meal programs scale. Providers that connect digital care and physician referral pathways will be better placed.

Who leads the food-as-medicine prescription services landscape?

Instacart Health and NourishedRx lead through grocery benefits and health-plan partnerships.

Food-as-medicine prescription services are used by health plans and members who need nutrition support tied to disease care. Instacart Health provides Fresh Funds and shoppable guidance that can support food-as-medicine programs. Season Health provides a platform that combines clinical nutrition care and meal delivery.

NourishedRx supports health plans using Food Is Medicine programs for chronic disease and care transitions. FarmboxRx provides produce delivery and nutrition education as a health-plan benefit. Performance Kitchen provides medically tailored meals developed by chefs and registered dietitians.

Competition through 2036 will depend on payer integration and outcomes reporting. Providers that combine clinical nutrition with benefit administration will be better placed. Grocery platforms can win produce prescription and stipend programs. Meal providers can win high-acuity chronic disease programs. Digital nutrition platforms can win employer and health-plan contracts if they show engagement and cost outcomes.

Which companies are the key players?

Instacart Health, Season Health, NourishedRx, FarmboxRx and Performance Kitchen.

• Instacart Health
• Season Health
• NourishedRx
• FarmboxRx
• Performance Kitchen

Bibliography

• [1] U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2025, November 19). Food Is Medicine: A project to unify and advance collective action.
• [2] Centers for Medicare & Medicaid Services. (2024, April 4). Contract Year 2025 Medicare Advantage and Part D Final Rule (CMS-4205-F).
• [3] U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2025, February). Food Is Medicine Landscape Summary.
• [4] American Diabetes Association Professional Practice Committee. (2025). 5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2025. Diabetes Care, 48(Supplement_1), S86–S127.
• [5] U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2024, September 12). Select Policy Pathways for Food Is Medicine Interventions.

This Report Addresses

• Strategic intelligence on food-as-medicine prescription services across service type, condition focus and customer type.
• Forecast mapping from USD 2.2 billion in 2026 to USD 35.0 billion by 2036.
• Segment analysis covering Medically Tailored Meals, Diabetes, Health Plans and Payers, Health-Plan Funded Benefit Programs and Chronic Disease Cost Reduction.
• Regional outlook covering the United States, Canada, United Kingdom, Australia and Germany.
• Competitive analysis of Instacart Health, Season Health, NourishedRx, FarmboxRx and Performance Kitchen.
• Service assessment covering medically tailored meals, produce prescriptions, medically tailored groceries and grocery benefit management.
• Condition assessment covering diabetes, cardiovascular disease, obesity, renal disease and maternal health.
• Primary interviews, provider checks, official source review and payer program validation support the forecast.

What does the food-as-medicine prescription services market cover?

Clinician-prescribed meals and grocery benefits for diet-related disease care.

The food-as-medicine prescription services market covers healthcare-linked food services that treat or manage diet-related disease. It includes medically tailored meals and grocery benefit management. The market differs from general meal delivery because food is prescribed and often funded through health plans or public programs.

What is included in the scope?

Prescribed meals and nutrition counseling.

The scope includes medically tailored meals designed for conditions such as diabetes and cancer. It covers produce prescriptions and dietitian-supported meal planning. It includes clinician referrals and condition-specific nutrition education. It also includes digital platforms that connect care teams with grocery ordering and delivery.

What is excluded from the scope?

General grocery delivery and wellness food subscriptions without clinical prescription.

The scope excludes standard meal kits and diet apps unless a clinical or payer-linked food prescription is included. It excludes restaurant delivery with no medical tailoring. It excludes general nutrition education without a food benefit. It also excludes food retail loyalty programs unless they are tied to prescribed nutrition support or reimbursed health benefits.

How was the analysis built?

100+ sources, 45+ company portfolios, 25+ countries, 20+ interviews.

• Primary Research:
  • Primary research includes interviews with health plan benefit teams and food-as-medicine providers. It includes input from registered dietitians and employer benefits leaders.
• Desk Research:
  • Desk research reviews HHS Food Is Medicine sources and provider service disclosures. It covers medically tailored meal programs and produce prescription models.
• Market-Sizing and Forecasting:
  • Forecasting uses diet-related chronic disease populations and program attachment rates. Medicaid pilots and employer-funded chronic care programs support the market assessment.
• Data Validation and Update Cycle:
  • Forecasts are validated through provider checks and payer program review. Policy updates and clinical nutrition program disclosures help confirm market direction.